We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CERS market cap is 315.43M. The company's latest EPS is USD -0.2068 and P/E is -8.46.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 46.34M | 25.05M | 38.48M | 55.23M | 47.25M |
Operating Income | -7.45M | -37.95M | -14.15M | -4.14M | -5.24M |
Net Income | -8.48M | -13.62M | -15.62M | -13.28M | -7.27M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 93.77M | 114.25M | 159.52M | 162.05M | 186.8M |
Operating Income | -66.23M | -58.33M | -48.94M | -62.08M | -30.05M |
Net Income | -71.24M | -59.86M | -54.37M | -42.78M | -37.49M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 215.4M | 218.09M | 209.34M | 198.86M | 205.84M |
Total Liabilities | 141.33M | 149.53M | 149.77M | 147.17M | 156.82M |
Total Equity | 74.07M | 68.56M | 59.56M | 51.69M | 49.02M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 165.54M | 221.42M | 237.5M | 218.09M | 197.75M |
Total Liabilities | 108.48M | 117.61M | 151.88M | 149.53M | 144.3M |
Total Equity | 57.05M | 103.81M | 85.62M | 68.56M | 53.44M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -23.86M | -25.62M | -8.5M | -17.5M | -27.99M |
Investing | 1.08M | 8.46M | -1.65M | 683k | 408k |
Financing | 3.74M | 4.19M | 2.06M | 1.89M | 9.49M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -65.84M | -40.74M | -33.92M | -25.62M | -43.17M |
Investing | 28.19M | -49.56M | 12.69M | 8.46M | 8.62M |
Financing | 43.49M | 91.78M | 34.29M | 4.19M | 10.67M |
Market Cap | 315.43M |
Price to Earnings Ratio | -8.46 |
Price to Sales Ratio | 1.7 |
Price to Cash Ratio | 27.26 |
Price to Book Ratio | 5.94 |
Dividend Yield | - |
Shares Outstanding | 181.28M |
Average Volume (1 week) | 861.77k |
Average Volume (1 Month) | 880.7k |
52 Week Change | -26.58% |
52 Week High | 3.08 |
52 Week Low | 1.205 |
Spread (Intraday) | 0.11 (6.32%) |
Company Name | Cerus Corp |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.cerus.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions